Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930524 · ClinicalTrials.gov registry record · NA
Adaptive Preventive Intervention for College Alcohol Use
A NA study of College Student Drinking, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 891
- Enrollment target
- 1
- Study location
NCT03930524: Completed NA study of College Student Drinking, sponsored by University of Minnesota.
NCT03930524 is a NA study of College Student Drinking that has completed, run by University of Minnesota. The registered enrollment target is 891 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03930524, a NA study of College Student Drinking, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 891 participants
- Enrollment target
- 1
- Study location
Study Summary
This research project is designed to promote health among first-year college students by implementing an adaptive sequence of preventive intervention strategies to motivate heavy-drinking college students to access existing resources in order to reduce high-risk alcohol use and negative consequences. If found efficacious, the adaptive preventive intervention (API) has the potential to reduce both the acute negative health consequences (e.g., injury, alcohol poisoning) and long-term health consequences (e.g., alcohol use disorders) of young adult alcohol use, while seeking to leverage technology in order to use campus resources in the most efficient way possible.
Primary Outcome
Respondents are asked about the frequency of consuming 4/5+ drinks within a two-hour period in the past 30 days. Questions are based on NIAAA recommended alcohol questions (https://www.niaaa.nih.gov/research/guidelines-and-resources/recommended-alcohol-questions) and Monitoring the Future survey items (http://www.monitoringthefuture.org/).
Conditions Studied
Interventions
- BEHAVIORAL Personalized Normative Feedback (PNF)
- BEHAVIORAL Self-Monitoring (SM)
- BEHAVIORAL Web-BASICS
- BEHAVIORAL Health Promotion Consultation
- BEHAVIORAL M-Bridge Online Health Coach
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 891 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
What the finished NCT03930524 record still lists
NCT03930524 is an interventional study that assigns participants to a tested intervention. The registered 891 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 1 condition, with College Student Drinking appearing as the primary indexed condition, and to 5 interventions - of which Personalized Normative Feedback (PNF) is the first listed.
NCT03930524 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03930524 about?
NCT03930524 is a clinical study titled "Adaptive Preventive Intervention for College Alcohol Use". This research project is designed to promote health among first-year college students by implementing an adaptive sequence of preventive intervention strategies to motivate heavy-drinking college students to access existing resources in order to reduce high-risk alcohol use and negative consequences...
What is the current status of trial NCT03930524?
This trial is currently completed. It is a NA study. The enrollment target is 891 participants. The study started on 2019-07-31. Estimated completion is 2022-08-01.
What conditions does trial NCT03930524 study?
This clinical trial studies the following conditions: College Student Drinking.
What interventions are being tested in trial NCT03930524?
The interventions under investigation include: Personalized Normative Feedback (PNF) (BEHAVIORAL), Self-Monitoring (SM) (BEHAVIORAL), Web-BASICS (BEHAVIORAL), Health Promotion Consultation (BEHAVIORAL), M-Bridge Online Health Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT03930524?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03930524 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03930524's enrollment target sits among peer trials
891 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI